230 related articles for article (PubMed ID: 12234020)
21. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival.
Bodí M; Rodríguez A; Solé-Violán J; Gilavert MC; Garnacho J; Blanquer J; Jimenez J; de la Torre MV; Sirvent JM; Almirall J; Doblas A; Badía JR; García F; Mendia A; Jordá R; Bobillo F; Vallés J; Broch MJ; Carrasco N; Herranz MA; Rello J;
Clin Infect Dis; 2005 Dec; 41(12):1709-16. PubMed ID: 16288392
[TBL] [Abstract][Full Text] [Related]
22. Explaining cost variations in clinical trials using severity of illness measures.
Shulkin DJ; Kinosian B; Glick H; Sirio C; Glen-Puschett C; Daly J
Clin Perform Qual Health Care; 1993; 1(3):134-7. PubMed ID: 10135625
[TBL] [Abstract][Full Text] [Related]
23. Management of community-acquired pneumonia by trained family general practitioners.
Potena A; Simoni M; Cellini M; Cartabellotta A; Ballerin L; Piattella M; Putinati S
Int J Tuberc Lung Dis; 2008 Jan; 12(1):19-25. PubMed ID: 18173872
[TBL] [Abstract][Full Text] [Related]
24. The effects of incorporating a pneumonia severity index into the admission protocol for community-acquired pneumonia.
Jo S; Kim K; Jung K; Rhee JE; Cho IS; Lee CC; Singer AJ
J Emerg Med; 2012 Feb; 42(2):133-8. PubMed ID: 20542398
[TBL] [Abstract][Full Text] [Related]
25. In-hospital observation after antibiotic switch in pneumonia: a national evaluation.
Nathan RV; Rhew DC; Murray C; Bratzler DW; Houck PM; Weingarten SR
Am J Med; 2006 Jun; 119(6):512.e1-7. PubMed ID: 16750965
[TBL] [Abstract][Full Text] [Related]
26. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
[TBL] [Abstract][Full Text] [Related]
27. Treatment costs associated with community-acquired pneumonia by community level of antimicrobial resistance.
Asche C; McAdam-Marx C; Seal B; Crookston B; Mullins CD
J Antimicrob Chemother; 2008 May; 61(5):1162-8. PubMed ID: 18310136
[TBL] [Abstract][Full Text] [Related]
28. Cost of Gram-negative resistance.
Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
[TBL] [Abstract][Full Text] [Related]
29. Management of community-acquired pneumonia and secular trends at different hospitals.
Capelastegui A; España PP; Quintana JM; Gorordo I; Gallardo MS; Idoiaga I; Bilbao A
Respir Med; 2005 Mar; 99(3):268-78. PubMed ID: 15733501
[TBL] [Abstract][Full Text] [Related]
30. Effect of a simple educational intervention on the hospital management of community-acquired pneumonia.
Serisier DJ; Bowler SD
Respirology; 2007 May; 12(3):389-93. PubMed ID: 17539843
[TBL] [Abstract][Full Text] [Related]
31. A teaching hospital's experience applying the Pneumonia Severity Index and antibiotic guidelines in the management of community-acquired pneumonia.
Lee RW; Lindstrom ST
Respirology; 2007 Sep; 12(5):754-8. PubMed ID: 17875067
[TBL] [Abstract][Full Text] [Related]
32. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.
Feldman RB; Rhew DC; Wong JY; Charles RA; Goetz MB;
Arch Intern Med; 2003 Jul; 163(14):1718-26. PubMed ID: 12885688
[TBL] [Abstract][Full Text] [Related]
33. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs?
Shorr AF; Micek ST; Jackson WL; Kollef MH
Crit Care Med; 2007 May; 35(5):1257-62. PubMed ID: 17414080
[TBL] [Abstract][Full Text] [Related]
34. Economic benefit of a 1-day reduction in hospital stay for community-acquired pneumonia (CAP).
Kozma CM; Dickson M; Raut MK; Mody S; Fisher AC; Schein JR; Mackowiak JI
J Med Econ; 2010; 13(4):719-27. PubMed ID: 21091099
[TBL] [Abstract][Full Text] [Related]
35. Outcome predictors of pneumonia in elderly patients: importance of functional assessment.
Torres OH; Muñoz J; Ruiz D; Ris J; Gich I; Coma E; Gurguí M; Vázquez G
J Am Geriatr Soc; 2004 Oct; 52(10):1603-9. PubMed ID: 15450034
[TBL] [Abstract][Full Text] [Related]
36. Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.
Lee RW; Lindstrom ST
Respirology; 2007 Jan; 12(1):111-6. PubMed ID: 17207035
[TBL] [Abstract][Full Text] [Related]
37. Albumin use guidelines and outcome in a surgical intensive care unit.
Charles A; Purtill M; Dickinson S; Kraft M; Pleva M; Meldrum C; Napolitano L
Arch Surg; 2008 Oct; 143(10):935-9; discussion 939. PubMed ID: 18936370
[TBL] [Abstract][Full Text] [Related]
38. Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care?
Nathwani D; Rubinstein E; Barlow G; Davey P
Clin Infect Dis; 2001 Mar; 32(5):728-41. PubMed ID: 11229840
[TBL] [Abstract][Full Text] [Related]
39. CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS.
Richards G; Levy H; Laterre PF; Feldman C; Woodward B; Bates BM; Qualy RL
J Intensive Care Med; 2011; 26(1):34-40. PubMed ID: 21341394
[TBL] [Abstract][Full Text] [Related]
40. Reducing door-to-antibiotic time in community-acquired pneumonia: Controlled before-and-after evaluation and cost-effectiveness analysis.
Barlow G; Nathwani D; Williams F; Ogston S; Winter J; Jones M; Slane P; Myers E; Sullivan F; Stevens N; Duffey R; Lowden K; Davey P
Thorax; 2007 Jan; 62(1):67-74. PubMed ID: 16928714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
